NVP DPP 728 - ≥98%, high purity , CAS No.247016-69-9

  • ≥98%
Item Number
N274739
Grouped product items
SKUSizeAvailabilityPrice Qty
N274739-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$49.90
N274739-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$119.90
N274739-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$200.90
N274739-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$429.90

Potent, selective, reversible DPP-IV inhibitor

Basic Description

SynonymsNVP-DPP728 | NVP-DPP-728 | NVP-728 | 6-(2-((2-((2S)-2-Cyanopyrrolidin-1-yl)-2-oxo-ethyl)amino)ethylamino)pyridine-3-carbonitrile
Specifications & Purity≥98%
Biochemical and Physiological MechanismsPotent, selective, reversible dipeptidyl peptidase-IV (DPP-IV) inhibitor (K i = 11 nM). Antidiabetic agent in vivo .
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

NVP-DPP728 is a potent, reversible, nitrile-dependent inhibitor of dipeptidyl peptidase IV (DPP-IV). NVP-DPP728 can inhibit the amide lysozyme activity of human DPP-IV with Ki of 11 nM. NVP-DPP728 inhibits the degradation of glukagon-like peptide-1 (GLP-1), thereby enhancing the release of insulin to glucose intake. NVP-DPP728 can be used in diabetes research

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 6-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile
INCHI InChI=1S/C15H18N6O/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20)/t13-/m0/s1
InChi Key VFFZWMWTUSXDCB-ZDUSSCGKSA-N
Canonical SMILES C1CC(N(C1)C(=O)CNCCNC2=NC=C(C=C2)C#N)C#N
Isomeric SMILES C1C[C@H](N(C1)C(=O)CNCCNC2=NC=C(C=C2)C#N)C#N
Alternate CAS 207556-62-5
PubChem CID 9796290
Molecular Weight 298.34

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
H2416187Certificate of AnalysisAug 08, 2024 N274739
H2416189Certificate of AnalysisAug 08, 2024 N274739
H2416190Certificate of AnalysisAug 08, 2024 N274739
H2416191Certificate of AnalysisAug 08, 2024 N274739
H2416192Certificate of AnalysisAug 08, 2024 N274739

Related Documents

Reviews

Customer Reviews

References

1. Löw K et al..  (2020)  A proopiomelanocortin-derived peptide sequence enhances plasma stability of peptide drugs..  FEBS Lett,  594  (17): (2840-2866).  [PMID:32506501]

Solution Calculators